INTRODUCTION
============

The global maternal death rate is decreasing every year; however, it remains high in many countries. In 2015, the maternal mortality ratio was 216 per 100,000 live births worldwide and 11 per 100,000 live births in South Korea \[[@b1-yujm-2018-35-2-248]\]. Although septic shock rarely occurs in pregnancy, infection is one of the most common direct causes of maternal death. Puerperal sepsis is estimated to cause the death of more than 75,000 pregnant women every year worldwide \[[@b2-yujm-2018-35-2-248]\].

The common clinical features of sepsis include fever, rigors, diarrhea, vomiting, rash, and abdominal or pelvic tenderness. Sepsis is diagnosed clinically; however, thorough investigations, including relevant imaging studies, blood cultures, and any other tests based on the clinical suspicion of the origin of infection, should be performed for the diagnostic workup. The intravenous administration of broad-spectrum antibiotics is the key treatment modality.

The most common organisms that cause puerperal sepsis are *Escherichia coli*, *Staphylococci*, and *Streptococci*. Particularly, infections caused by group A Streptococci are widely responsible for severe maternal sepsis and death. In addition, it is well known that staphylococcal toxic shock syndrome (TSS), caused by *staphylococcus* aureus, is a life-threatening illness that is associated with necrotizing fasciitis. However, few case reports or case series have reported *staphylococcus caprae* as a cause of human infection. Here, we report a rare case of necrotizing fasciitis after a cesarean section. This is the first report of a human isolate of *S. caprae* in association with puerperal sepsis and necrotizing fasciitis.

CASE
====

**Patient:** Female, 30 years old.

**Presenting complaint:** A sudden gush of clear fluid from the vagina.

**Obstetric history:** 1-0-0-1, a history of vaginal delivery at term, 1 year ago.

**History of presenting complaint:** A woman with a singleton pregnancy at 26 weeks of gestation, visited a local clinic because of abdominal pain and vaginal leakage of amniotic fluid that occurred four hours prior to presentation. She was diagnosed with preterm labor and membrane rupture and was referred to our emergency department.

**Past history:** She conceived naturally and was followed up regularly at an obstetric clinic from an early gestational age. There were no specific findings in her antenatal course or in her medical or surgical history. She was taking oral folic acid and iron supplements.

Physical examination: At presentation, the patient showed the following: body mass index, 21.2 kg/m^2^; blood pressure, 110/80mmHg; pulse rate, 88 beats/min; and body temperature, 37.5℃. On speculum examination, there was a large volume of clear fluid in the vagina, which was positive to the nitrazine test.

**Laboratory findings:** Blood testing showed increased levels of white blood cells (WBC), 16,430/mm^3^; neutrophils, 82.7%; and C-reactive protein (CRP), 1.9mg/dL (range, \<0.5mg/dL). Hemoglobin levels and platelet counts were normal. The results of the coagulation profile, liver function test, renal function test, and urine analysis were normal. Tests for congenital intrauterine infection and sexually transmitted diseases were not performed at patient presentation.

**Imaging findings:** Ultrasonography showed the fetus in a breech presentation, with an estimated fetal weight of 750 g (9th percentile) and an amniotic fluid index of 1.6 cm. The cervical length was 1.8 cm. On electronic fetal monitoring, the fetal heart rate was 148 beats/min with moderate variability, and there were uterine contractions every 2-3 min.

**Management and clinical progress:** Since she was hospitalized, absolute bed rest was recommended, and several medications, including dexamethasone, ritodrine, and ceftezole, were intravenously administered. Although a small amount of fluid leakage continued from her vagina, the abdominal pain improved after admission, and her body temperature remained normal at 36.9℃.

Three days after hospital admission (at 26+3 weeks of gestation), the patient complained of a headache with myalgia, and her body temperature was 38.2℃. With a clinical diagnosis of chorioamnionitis, the patient underwent an emergency cesarean section. At surgery, there was no meconium in the amniotic fluid, but both the amniotic membrane and uterine endometrium were stained yellow. After delivery of the placenta, a swab culture from the endometrium was obtained, in which an extended-spectrum β-lactamase-producing *E. coli* was isolated. During surgery, no significant hemorrhage or surgical complication occurred.

Thirty minutes after the end of surgery, she experienced a sudden onset of massive vaginal bleeding. Evaluation showed the following: blood pressure, 90/40mmHg; pulse rate, 128 beats/min; and body temperature, 39.5℃. Her mental state became drowsy, and a boggy uterus was palpable above the umbilicus. Since her central venous pressure was below 3mmHg, a large volume of intravenous fluid was infused, and a transfusion was performed. The estimated blood loss was approximately 1,000mL, and the patient was suspected to have uterine atony, complicated by septic shock. We managed the patient with oxygen delivered via nasal cannula, intravenous administration of uterine tonics (methylergometrine and carbetocin), antibiotics (ceftriaxone and metronidazole), and antipyretics. Arterial blood gas analysis showed metabolic acidosis (pH, 7.33; pCO~2~, 27mmHg; pO~2~, 147mmHg; base excess, -10.2mmol/L; HCO3-, 14.1mmol/L; and lactate, 1.8 mmol/L). The blood test results, including increased levels of WBC (33,510/mm^3^), CRP (15.4mg/dL), procalcitonin (42.1 ng/mL; range, \<0.5 ng/mL), and D-dimer (324 μg/mL); decreased levels of hemoglobin (7.1 g/dL), platelets (76,000/mm^3^), antithrombin III (48%), and fibrinogen (\<80 mg/dL); and prolonged times of prothrombin and activated partial thromboplastin, were consistent with infection and disseminated intravascular coagulation. Cultures from blood, urine, and sputum all yielded negative results. On transvaginal sonography, there was no significant finding in the uterus, and both the cervix and vagina were normal. After several minutes of uterine massage, uterine contractions were ensured, and vaginal bleeding was controlled. The patient was admitted to the intensive care unit (ICU), and treated with an intravenous administration of tranexamic acid, anti-thrombin III, and norepinephrine. Two days after surgery, the antibiotics were changed to a combination of ampicillin/sulbactam and metronidazole based on the assumption of sepsis caused by group A Streptococcus. However, because a swab culture of vaginal discharge yielded an extended-spectrum β-lactamase-producing E. coli, the antibiotics were changed to intravenous ertapenem(1 g, once a day) on the fifth day after surgery.

After treatment, her condition and laboratory findings improved, but fever, up to 39℃ recurred, and both WBC(18,160/mm^3^) and CRP (30.3mg/dL) levels increased again on the seventh postoperative day. She presented tenderness in the lower abdomen and vulva. Exudate discharge from the cesarean scar was detected, and inflamed necrotic skin with severe edema, a color change to dark, and scaling were observed on her vulva. Because a clinical diagnosis of surgical site infection with necrotizing fasciitis caused by uterine infection was made, the cesarean fascia scar was opened. During surgical exploration, loculated fluid with necrotic tissue was observed, so debridement with copious irrigation using a Versajet was performed under local anesthesia. On postoperative computed tomography, there was no evidence of either intraabdominal abscess or pelvic thrombophlebitis ([Fig. 1](#f1-yujm-2018-35-2-248){ref-type="fig"}). A culture of the pus collected from the abdominal fascia yielded penicillin-sensitive *staphylococcus caprae*. A combination of ertapenem and ampicillin/sulbactam was administered, and aggressive debridement with wound dressing was performed daily. A gradual return to the normal appearance of both the abdominal wound and vulva was observed. Other symptoms, including myalgia, diarrhea, diffuse skin rash, and pleural effusion progressively improved. Two weeks after surgical exploration, the abdominal wound was closed using a local advancement flap by plastic surgeons. The patient was discharged one week after the repair surgery, without evidence of wound complications.

At birth, the neonatal weight was 840 g, and Apgar scores were 5 at 1 min and 7 at 5 min. After being managed with a mechanical ventilator in the neonatal ICU, the neonate was discharged 3 months after birth and has been healthy during 1 year of follow-up.

DISCUSSION
==========

In 2012, the Royal College of Obstetricians and Gynaecologists released the Green-top Guidelines regarding the diagnostic criteria and management recommendations for bacterial sepsis in pregnancy \[[@b3-yujm-2018-35-2-248]\] and following pregnancy \[[@b4-yujm-2018-35-2-248]\]. Based on these guidelines, the present case can be diagnosed as puerperal sepsis and is classified as a probable case of staphylococcal toxic shock. Multiple risk factors for puerperal infection have been reported in the literature, and the delivery mode of cesarean section is the single most powerful factor \[[@b2-yujm-2018-35-2-248]\]. Other risk factors include vaginal discharge and prolonged spontaneous rupture of membranes, which corresponds with the features of the present case. Additional factors, such as obesity, diabetes, anemia, immunosuppressed condition, and a history of pelvic infection, are also associated with an increased risk of puerperal infection.

The most common organisms that cause puerperal sepsis are *E. coli*, *staphylococcus*, and *Streptococcus*. Other organisms include *Klebsiella, Clostridium sordellii, Mycoplasma, Chlamydia*, and coliform bacteria \[[@b5-yujm-2018-35-2-248]\]. In a prospective cohort study of 151 women who experienced puerperal sepsis, the authors found that the most common bacterial isolates were *E. coli* (30.6%) and *Klebsiella pneumoniae* (15.3%), followed by coagulase-negative staphylococci and S. aureus \[[@b6-yujm-2018-35-2-248]\]. It has long been recognized that strains of *S. aureus*, which cause TSS, are capable of producing several toxins, such as TSS toxin-1 (TSST-1) and other enterotoxins. However, little is known about *S. caprae* as a causative organism in human infections.

*S. caprae* is a coagulase-negative, Gram-positive coccus that is mainly isolated from animals and was first isolated from goat's milk in 1983 \[[@b7-yujm-2018-35-2-248]\]. The incidence rate of *S. caprae* infection in humans is unclear. In a large study, staphylococcal species were genetically identified by DNA-DNA hybridization, and 10.7% of 1,230 staphylococcal strains were *S. caprae*, suggesting that this organism is widely distributed in human clinical specimens \[[@b8-yujm-2018-35-2-248]\]. In contrast, in a study of patients with acute otitis externa, among the 107 coagulase-negative staphylococci recovered from clinical specimens, only one strain was *S. caprae* \[[@b9-yujm-2018-35-2-248]\]. Whether *S. caprae* was the true cause of the infections in these published cases is unclear. In a study of goat specimens, three (16.5%) out of 86 staphylococcal strains that produced TSST-1 were *S. caprae* \[[@b10-yujm-2018-35-2-248]\]. In a few studies of human clinical specimens, *S. caprae* was isolated from patients with endocarditis, acute otitis externa, bone and joint infections, urinary tract infections, meningitis, and bacteremia, as well as from infants in neonatal ICUs. Most of these infections were hospital acquired, and a few were community acquired. The first human case of *S. caprae* meningitis, which was described in 2008, was associated with a nosocomial infection of an intraspinal device \[[@b11-yujm-2018-35-2-248]\]. In addition, Vandenesch et al. \[[@b12-yujm-2018-35-2-248]\] reported five cases of human infection with *S. caprae* and stated that this organism is a human pathogen responsible for severe clinical diseases both in the hospital and in the community.

In the present case, the diagnosis was based on a positive culture result and gross evidence of a necrotic wound during surgical debridement, from which *S. caprae* was isolated by culture. The culture result indicates that the secondary wound infection and necrotizing fasciitis were caused by *S. caprae*, following the ascending infection of the uterus from the vagina caused by E. coli. Thus, the patient likely acquired *S. caprae* during her hospital stay. However, the actual timing of the infection is unknown because all samples were obtained after the administration of antibiotics.

*S. caprae* is usually sensitive to most anti-staphylococcal antibiotics, including penicillin; however, some resistance to methicillin has been reported \[[@b13-yujm-2018-35-2-248]\]. Furthermore, a recent study showed that *S. caprae* and methicillin-resistant *S. aureus* share phenotypic and genotypic characteristics, and are capable of persisting for a long time, particularly in an ICU setting \[[@b14-yujm-2018-35-2-248]\]. Maternal sepsis can rapidly progress to septic shock, which has a mortality rate of 20-28%\[[@b15-yujm-2018-35-2-248]\]. Therefore, knowledge of this infrequently isolated organism is essential, particularly in ICU settings, to promote early identification and appropriate management.

Early detection of sepsis is particularly challenging during pregnancy and the postpartum period due to its insidious onset. A delay in the diagnosis of septic shock is one of the factors predicting poor prognosis. The clinical information in the present case extends our knowledge of *S. caprae*, a rarely reported organism in humans with severe infection. To the best of our knowledge, this is the first report of necrotizing fasciitis caused by *S. caprae* complicated by puerperal septic shock.
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